Compugen (CGEN) Shares Outstanding (Diluted Average) (2009 - 2025)

Compugen's (CGEN) quarterly Shares Outstanding (Diluted Average) came in at $93.5 million in Q3 2025, up 4.14% year-on-year from $89.8 million in Q3 2024, and up 58461503.12% quarter-over-quarter from $160.0 in Q2 2025.

Compugen (CGEN) Shares Outstanding (Diluted Average) (2009 - 2025) Analysis & Trends

Compugen has disclosed Shares Outstanding (Diluted Average) across 15 years of filings, most recently posting $93.5 million for Q3 2025.

  • Shares Outstanding (Diluted Average) for Q3 2025 came in at $93.5 million, up 4.14% year-over-year; the trailing twelve-month figure through Sep 2025 was $93.5 million (up 4.14% YoY), and the FY2015 annual result was $50.5 million, up 0.76% from the prior year.
  • Shares Outstanding (Diluted Average) came in at $93.5 million for Q3 2025 at Compugen, up from $160.0 in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $93.5 million in Q3 2025 to a low of $100.0 in Q2 2024.
  • The 5-year median for Shares Outstanding (Diluted Average) is $43.5 million (2021), against an average of $44.8 million.
  • Across the five-year window, Shares Outstanding (Diluted Average) surged 39501600.45% in 2023 and tumbled 100.0% in 2024, its largest moves.
  • Compugen's Shares Outstanding (Diluted Average) stood at $230.0 in 2021, then dropped by 4.35% to $220.0 in 2022, then soared by 40140958.64% to $88.3 million in 2023, then increased by 1.71% to $89.8 million in 2024, then grew by 4.14% to $93.5 million in 2025.
  • The last three Shares Outstanding (Diluted Average) figures came in at $93.5 million (Q3 2025), $160.0 (Q2 2025), and $89.8 million (Q3 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4,489.46 Bn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 810.00
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 118.76 Bn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 1.48 Bn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 256.30 Mn
9 Abivax 91.96 Bn 91.96 Bn - 92.44 Mn
10 Compugen 189.59 Mn 97.83 Mn 352,000.00 -

Historic Data

Download Data
DateValue
Sep 30, 2025 93.54 Mn
Jun 30, 2025 160.00
Sep 30, 2024 89.82 Mn
Jun 30, 2024 100.00
Sep 30, 2023 88.31 Mn
Jun 30, 2023 86.90 Mn
Jun 30, 2022 220.00
Jun 30, 2021 230.00
Mar 31, 2019 60.02 Mn
Mar 31, 2018 51.98 Mn
Mar 31, 2017 51.13 Mn
Dec 31, 2015 50.53 Mn
Jun 30, 2015 50.41 Mn
Dec 31, 2014 50.14 Mn
Jun 30, 2014 49.80 Mn
Dec 31, 2013 42.74 Mn
Sep 30, 2013 39.15 Mn
Jun 30, 2013 39.14 Mn
Dec 31, 2012 36.25 Mn
Sep 30, 2012 36.80 Mn